Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltitrexed + RT in Elderly Esophageal SCC
NCT03585530Phase 2Unknown
- Start
- Sep 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltitrexed in Esophageal Squamous Cell Carcinoma (ESCC). Status: unknown.
02
Drugs
raltitrexed
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03585530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03585530.